您的位置:PharmaNews 研发动态 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

Abbott's Simcor ( niacin extended-release / simvastatin ) Receives FDA Approval for New Dosage Strengths(2)
本文章共1940字,分2页,当前第2页,快速翻页:

More information about SIMCOR, including full prescribing information, is available on the Web site http://www.rxabbott.com/pdf/simcor_pi.pdf, or by calling Abbott Medical Information at 1-800-633-9110.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 83,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com. Media:


SOURCE Abbott

转载自pharmaLive


 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

  FDA Approves Drug for Chronic Drooling i

  Quintiles Announces New European Headqua

  Covance Reports Second Quarter Revenue o

  Commonwealth Biotechnologies, Inc. Provi

Abraxis BioScience and Specialised Thera

Shionogi Inc. Announces FDA Approval of

Researchers Solve Mystery of Uner Tan Sy

WaferGen Announces Purchase of SmartChip

Plant Compound Resveratrol Shown to Supp

New pathway to Parkinson's and Alzheimer

deCODE Shows how Genetic Risk of Kidney

Bionovo to Advance Menerba to Phase 3 Cl

Geron to Proceed with First Human Clinic

Orexigen Therapeutics Announces Publicat

相关评论

    
本文章所属分类:首页 研发动态